Title |
Pancreatic mucinous cystic neoplasm in a transgender patient
|
---|---|
Published in |
World Journal of Surgical Oncology, June 2015
|
DOI | 10.1186/s12957-015-0620-8 |
Pubmed ID | |
Authors |
Deshka Foster, Mohammad F. Shaikh, Elizabeth Gleeson, Blake D. Babcock, Jianping Lin, Robert T. Ownbey, Mark E. Hysell, Daniel Ringold, Wilbur B. Bowne |
Abstract |
Cystic pancreatic lesions are increasingly more frequent detected clinical entities. Mucinous cystic neoplasm (MCN) is a hormone-related pancreatic tumor (HRTP) with a strong predominance in young and middle-aged females. Here, we present the case of a 31-year-old surgically transgendered female-to-male patient with a history of alcoholic pancreatitis, on chronic testosterone therapy. He was found to have a pancreatic MCN and underwent distal pancreatectomy and splenectomy. To our knowledge, this is the first reported case of a transgender patient with a history of hormone replacement therapy (HRT) and pancreatic MCN. We consider possible mechanisms for the pathogenesis to explain this patient's neoplasm. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 23% |
Other | 5 | 17% |
Student > Master | 4 | 13% |
Student > Bachelor | 3 | 10% |
Professor | 1 | 3% |
Other | 3 | 10% |
Unknown | 7 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 63% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Psychology | 1 | 3% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Unknown | 8 | 27% |